What happened

Mobile-health Network Solutions (NASDAQ: MNDR) raised its standby equity line with YA II PN, Ltd. (Yorkville) to up to $30 million from $10 million. The amendment is dated Nov. 11. The original agreement dates from Feb. 14, 2025.

Under the line, the company may sell Class A ordinary shares to Yorkville but does not have to. Yorkville must buy them, subject to conditions. The agreement ends on Dec. 31, 2028 at the latest, or sooner if Yorkville has paid advances equal to the full commitment.

As of Nov. 11, Yorkville had bought $5.49 million of shares. That left $4.51 million under the old limit.

The company also owes Yorkville a commitment fee of 1.00% of the $20 million increase, or $200,000, within three days of Nov. 11. It can pay in cash or by issuing 200,000 Ordinary Shares.

Why it matters

The amendment gives the company far more room to raise cash by selling stock. That bears on the liquidity question in OptimistFi's view that MNDR's value depends on demand, gross margin and cash burn recovering together before liquidity forces dilution.

A larger line is a funding option. Each draw would mean new shares issued to Yorkville. The fee adds shares too if the company pays it in stock.

The facility is a ceiling, not cash raised. The company cannot request any advances until a registration statement covering Yorkville's resale of the shares takes effect. The filing says proceeds will be used as set out in the prospectus. OptimistFi reads the amendment as mixed for the case.

Explain the financial terms

A profit margin expresses the specified profit measure as a share of sales.

What's next

Before it delivers any advance notice, the company must file a Form F-1 registration statement for Yorkville's resale of the shares. Sales can begin only after it takes effect.

The first advance notice after that would show whether the company starts drawing on the line. Heavy use would test the dilution risk in OptimistFi's case. An untouched line would leave the liquidity picture where it stood.

Sources checked automatically Nov 18, 2026 · Human review: none
Thesis impactMNDR: no published thesis yet.